Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Medtronic
AstraZeneca
Express Scripts
Dow

Last Updated: December 7, 2022

Loxapine succinate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Drug Prices for loxapine succinate

See drug prices for loxapine succinate

Recent Clinical Trials for loxapine succinate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Witten/HerdeckePhase 2
Mylan PharmaceuticalsPhase 1

See all loxapine succinate clinical trials

US Patents and Regulatory Information for loxapine succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm LOXITANE loxapine succinate CAPSULE;ORAL 017525-004 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Rising LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 076762-004 Nov 1, 2004 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Rising LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 076762-001 Nov 1, 2004 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Rising LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 076762-002 Nov 1, 2004 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lannett Co Inc LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 090695-003 Sep 26, 2011 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Elite Labs Inc LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 076868-001 Aug 4, 2005 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for loxapine succinate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm LOXITANE loxapine succinate CAPSULE;ORAL 017525-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Teva Branded Pharm LOXITANE loxapine succinate CAPSULE;ORAL 017525-004 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Teva Branded Pharm LOXITANE loxapine succinate CAPSULE;ORAL 017525-003 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Teva Branded Pharm LOXITANE loxapine succinate CAPSULE;ORAL 017525-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Baxter
Moodys
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.